Showing results (171-180 of 790) with videos related to

Sort By:
Pageof 79
The Journal of Nutrition|October 1, 1991
Nutrient balance and stage of lactation affect responses of insulin, insulin-like growth factors I and II, and insulin-like growth factor-binding protein 2 to somatotropin administration in dairy cowsJ L Vicini, F C Buonomo, J J Veenhuizen, et al.
Endocrinology|August 1, 1991
The direct in vitro effect of insulin-like growth factors (IGFs) on normal bovine mammary cell proliferation and production of IGF binding proteinsM F McGrath, R J Collier, D R Clemmons, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|July 12, 2005
Rh/IGF-I/rhIGFBP-3 administration to patients with type 2 diabetes mellitus reduces insulin requirements while also lowering fasting glucoseD R Clemmons, A C Moses, A Sommer, et al.
Biochemical and Biophysical Research Communications|May 16, 1988
Cloning, characterization, and expression of a human insulin-like growth factor binding proteinM T Brewer, G L Stetler, C H Squires, et al.
Clinical Endocrinology|October 1, 1982
Changes in circulating somatomedin-C levels in bromocriptine-treated acromegalyJ A Wass, D R Clemmons, L E Underwood, et al.
Endocrinology|September 1, 1990
Regulation of serum insulin-like growth factor-I (IGF-I) and IGF binding proteins during rat pregnancyM L Davenport, D R Clemmons, M V Miles, et al.
Endocrinology|July 1, 1990
Insulin differentially alters transcapillary movement of intravascular IGFBP-1, IGFBP-2 and endothelial cell IGF-binding proteins in the rat heartR S Bar, M Boes, D R Clemmons, et al.
The American Journal of Medicine|October 1, 1980
Estradiol treatment of acromegaly. Reduction of immunoreactive somatomedin-C and improvement in metabolic statusD R Clemmons, L E Underwood, E C Ridgway, et al.
The New England Journal of Medicine|November 22, 1979
Evaluation of acromegaly by radioimmunoassay of somatomedin-CD R Clemmons, J J Van Wyk, E C Ridgway, et al.
The Journal of Clinical Endocrinology and Metabolism|February 19, 1998
MK-677, an orally active growth hormone secretagogue, reverses diet-induced catabolismM G Murphy, L M Plunkett, B J Gertz, et al.
Pageof 79